3. Amsterdam EA, et al. A perspective on hyperlipidemia. Concepts of management in the prevention of coronary artery disease. Am J Med 105 (1ª): 69s-74s, 1998.

4. Primary prevention of acute coronary events with lovastatinin men and women with average cholesterol levels: results of the AFCAPS/TexCAPS. JAMA 279: 1615-1622, 1998.

5. Deedwania P. , et al. Evidence based, cost effective risk stratification and management after myocardial infarction. Arch Intern Med 157: 273-280, 1997.

6. Garber A. , et al. Cholesterol screening in asymptomatic adults, revisited. Annals of Int Med, 124 (5): 518-530, 1996.

7. Helsinki heart study: primary prevention trial with gemfibrozil in middle aged men with dyslipidemia. N Engl J Med 317: 20, 1987.

8. Relation of high density lipoprotein cholesterol and tryglicerides to incidence of atherosclerotic coronary disease (the PROCAM experience). Am J Cardiol 70: 733-737, 1992.
Autor: FUNDACION SANTAFE DE BOGOTA
 
<< Pgina Anterior           Pgina Siguiente >> 

[Pgina 1]    [Pgina 2]    [Pgina 3]    [Pgina 4]    [Pgina 5]    [Pgina 6]    
[Pgina 7]